Microbicide Trials Network

RMP-02/MTN-006

A Phase I safety, acceptability and drug absorption study of tenofovir vaginal gel applied rectally and tenofovir tablets taken orally that was conducted in collaboration with the University of California, Los Angeles (UCLA) through the Integrated Preclinical/Clinical Program for HIV Topical Microbicides, National Institute of Allergy and Infectious Diseases.
 
See
28-February-2011
  
28-February-2011
  
28-February-2011
     
28-February-2011
 
25-March-2014
 
See Also